Portfolio Update

RNS Number : 3751N

Intl. Biotechnology Trust PLC

17 January 2019

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 December 2018

Net Assets	£209m
Net Assets per share	556p
Share price	570p
Total value of unquoted investments	£30m
Total number of portfolio companies	61
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Incyte	6.1
Vertex	5.6
Celgene	5.4
Genmab	5.1
Gilead Sciences	5.0
Regeneron	4.4
Exelixis	4.4
Illumina	3.8
Neurocrine	3.4
Biomarin	3.0
	-----------
Total	46.2

Geographical Allocation	% NAV
US & Canada	87
Europe	13
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	85
Unquoted	15
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	44
Mid Cap =USD1-10BN	33
Small Cap <USD1BN	23
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	35
Rare diseases	21
CNS	10
Ophthalmology	5
Infectious Diseases	5
Tools	4
Inflammation	3
Medtech	3
Metabolic	0
Other	14
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

17 JANUARY 2019

 

END

 

 

PFUGIGDBIUBBGCR